---
layout: post
title: "Breakthrough Devices Program; Guidance for Industry and Food and Drug Administration Staff; Availability"
date: 2026-02-05 18:56:50 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-20007
original_published: 2023-09-15 00:00:00 +0000
significance: 8.00
---

# Breakthrough Devices Program; Guidance for Industry and Food and Drug Administration Staff; Availability

**Published:** February 05, 2026 18:56 UTC
**Source:** Federal Register
**Original Published:** September 15, 2023 00:00 UTC
**Document Number:** 2023-20007

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled "Breakthrough Devices Program." This final guidance describes policies that FDA intends to use to implement a section of the Federal Food, Drug, and Cosmetic Act (FD&C Act). This guidance updates the previous version of the guidance, of the same title, issued on December 18, 2018, and describes how the Breakthrough Devices Program may also be applicable to certain devices that benefit populations impacted by health and/or healthcare disparities. Consistent with our obligations under the SUPPORT for Patients and Communities Act (SUPPORT Act), the Breakthrough Devices Program may be available for certain non-addictive medical products to treat pain or addiction.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/09/15/2023-20007/breakthrough-devices-program-guidance-for-industry-and-food-and-drug-administration-staff)
- API: https://www.federalregister.gov/api/v1/documents/2023-20007

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
